Novartis AG (SWX: NOVN)
Switzerland
· Delayed Price · Currency is CHF 95.58
+1.78 (1.90%)
Jan 31, 2025, 5:30 PM CET
Novartis AG Employees
Novartis AG had 76,057 employees as of December 31, 2023. The number of employees decreased by 25,646 or -25.22% compared to the previous year.
Employees
76,057
Change (1Y)
-25,646
Growth (1Y)
-25.22%
Revenue / Employee
616.24K CHF
Profits / Employee
142.27K CHF
Market Cap
188.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
| Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
| Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
| Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
| Dec 31, 2019 | 103,914 | -21,247 | -16.98% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,605 |
| Lonza Group AG | 18,000 |
| Alcon | 25,315 |
| Galderma Group AG | 6,545 |
| Straumann Holding AG | 11,109 |
| Sandoz Group AG | 22,633 |
| Sonova Holding AG | 18,151 |
| Ypsomed Holding AG | 2,296 |
Novartis AG News
- 1 day ago - Novartis AG 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 1 day ago - Novartis targets 5%+ annual sales growth through 2029 amid robust brand performance - Seeking Alpha
- 1 day ago - Novartis AG (NVS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Novartis delays Phase 3 readout for Ionis heart drug - Seeking Alpha
- 1 day ago - Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker - Investor's Business Daily
- 1 day ago - Novartis proposes dividend raise to CHF 3.50 - Seeking Alpha
- 1 day ago - Novartis (NVS) Surges on Strong Q4 Earnings and Robust Drug Sales - GuruFocus
- 1 day ago - Novartis Q4: Earnings Beat Estimates, CEO Dismisses Entresto Patent Expiration Worries - Benzinga